ES2054238T3 - Nuevo metodo de induccion de la ovulacion en humanos. - Google Patents

Nuevo metodo de induccion de la ovulacion en humanos.

Info

Publication number
ES2054238T3
ES2054238T3 ES90302841T ES90302841T ES2054238T3 ES 2054238 T3 ES2054238 T3 ES 2054238T3 ES 90302841 T ES90302841 T ES 90302841T ES 90302841 T ES90302841 T ES 90302841T ES 2054238 T3 ES2054238 T3 ES 2054238T3
Authority
ES
Spain
Prior art keywords
ovulation
humans
induction
new method
distinguishable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90302841T
Other languages
English (en)
Inventor
Scott C Chappel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Research Systems ARS Holding NV
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Application granted granted Critical
Publication of ES2054238T3 publication Critical patent/ES2054238T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

ESTAN DISPUESTOS NUEVOS METODOS PARA INDUCIR A LA OVULACION HUMANA POR ADMINISTRACION SECUENCIAL DE UNA PLURALIDAD DE PREPARACIONES DE FSH RECOMBINANTE CADA UNA DE LAS CUALES TIENEN UN PLASMA DISTINGUIBLE DE MEDIA VIDA.
ES90302841T 1989-03-17 1990-03-16 Nuevo metodo de induccion de la ovulacion en humanos. Expired - Lifetime ES2054238T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/324,949 US5087615A (en) 1989-03-17 1989-03-17 Novel method of ovulation induction in humans

Publications (1)

Publication Number Publication Date
ES2054238T3 true ES2054238T3 (es) 1994-08-01

Family

ID=23265819

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90302841T Expired - Lifetime ES2054238T3 (es) 1989-03-17 1990-03-16 Nuevo metodo de induccion de la ovulacion en humanos.

Country Status (10)

Country Link
US (2) US5087615A (es)
EP (1) EP0388223B1 (es)
JP (1) JP2553729B2 (es)
AT (1) ATE106744T1 (es)
CA (1) CA2012170C (es)
DE (1) DE69009548T2 (es)
DK (1) DK0388223T3 (es)
ES (1) ES2054238T3 (es)
HK (1) HK143495A (es)
MX (1) MX9203348A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
HUT76660A (en) * 1994-01-20 1997-10-28 Akzo Nobel Nv New composition of glycoprotein isoforms having follicle stimulating activity
US20030166525A1 (en) * 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
UA78676C2 (en) * 2000-02-22 2007-04-25 Applied Research Systems Purified lh
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
US6953774B2 (en) * 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation
EA007030B1 (ru) * 2001-10-22 2006-06-30 Апплайд Резеч Системз Арс Холдинг Н.В. Гонадотропины для фолликулогенеза
WO2003051344A1 (en) * 2001-12-14 2003-06-26 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation_using a non-polypeptide camp level modulator
KR101105486B1 (ko) * 2003-04-02 2012-01-13 아레스 트레이딩 에스.에이. Ｆｓｈ 및 ｌｈ과 비이온성 계면활성제의 액상 약제학적 제제
ES2414705T3 (es) * 2003-06-20 2013-07-22 Ares Trading S.A. Formulaciones liofilizadas de FSH/LH

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923805A (en) * 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US4589402A (en) * 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
AU601421B2 (en) * 1986-05-02 1990-09-13 Betrola Investments Pty Ltd Method of regulating animal reproduction
CA1317534C (en) * 1987-03-17 1993-05-11 Arthur Newton Ley Method of enumerating escherichia coli
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario

Also Published As

Publication number Publication date
DK0388223T3 (da) 1994-07-04
MX9203348A (es) 1992-09-01
JP2553729B2 (ja) 1996-11-13
HK143495A (en) 1995-09-15
DE69009548D1 (de) 1994-07-14
DE69009548T2 (de) 1994-09-29
US5262518A (en) 1993-11-16
ATE106744T1 (de) 1994-06-15
CA2012170A1 (en) 1990-09-17
CA2012170C (en) 2000-05-02
EP0388223A2 (en) 1990-09-19
JPH03246231A (ja) 1991-11-01
EP0388223B1 (en) 1994-06-08
US5087615A (en) 1992-02-11
EP0388223A3 (en) 1991-03-06

Similar Documents

Publication Publication Date Title
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
DE68924162D1 (de) Stressproteine und verwendungen dafür.
FI920184A (fi) Apparat foer artroskopisk knaekirurgi.
PT76546B (en) Process for preparing functional human urokinase protein
HU9300036D0 (en) Method for producing o-glycosylized alpha-interferons and pharmaceutical preparatives containing them
ES2054238T3 (es) Nuevo metodo de induccion de la ovulacion en humanos.
TW221056B (es)
HU9301794D0 (en) Medical preparative for treating chronical viral diseases of liver as well qs method for preparing said medicament
DE69027472T2 (de) Arylsubstituierte Rhodaninderivate
AU3346289A (en) Heparin-binding proteins, DNA coding for them, processes for producing them as well as therapeutic preparations containing them
DK0393502T3 (da) Opløselige interferon-gamma-receptorer og fremgangsmåder til fremstilling heraf
HUT52819A (en) Process for producing polypeptides suitable for diagnosing mycoplasmic contamination of swine, by way of recombinant dna technique
HUT55800A (en) Process for producing anticoagulant peptides
KR950700684A (ko) 시클릭 항-종양 촉진제 화합물, 그의 조성물, 제조 방법 및 용도(Cyclic Anti-Tumor Promoter Compounds, Compositions and Methods for Production and Use)
HUT53125A (en) Process for producing peptides with anticoagulant activity
DE69011144T2 (de) Opthalmologischer Apparat.
KR950701347A (ko) 신규한 향종양성 사이토킨(A novel anti-neoplastic cytokine)
EP0314016A3 (en) Switch bag type blood-gathering set, operating panel apparatus of said blood-gathering set and blood-gathering method by using said blood-gathering set
IT1227283B (it) Metodo per preparare 1,1,1 trifluoro-2,2- di cloroetano da trifluorotricloroetano
FI874726A0 (fi) Kirurgisk apparat.
NO913550L (no) Apparat for flytting av pasienter.
NO913298D0 (no) Terapeutisk aerosolpreparater.
IT8349430A0 (it) Metodo per la produzione di proteine antigeniche specifiche del virusdell'epatite umana a, loro utilizzazione per la produzione di preparazioni farmaceutiche e mezzi diagnostici
FR2711137B1 (fr) Allylaminoesters, leur procédé de préparation et leur application en thérapeutique.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 388223

Country of ref document: ES